What does Xeris Biopharma Holdings, Inc. do?

Jun 22 2025 07:12 PM IST
share
Share Via
Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing injectable and infusible drug formulations. As of March 2025, it reported net sales of $60 million and a net loss of $9 million, with a market cap of $727.10 million.
Overview:
Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company engaged in developing and commercializing injectable and infusible drug formulations within the Pharmaceuticals & Biotechnology industry.

Financial Snapshot:
- Most recent Net Sales: 60 Million (Quarterly Results - Mar 2025)
- Most recent Net Profit: -9 Million (Quarterly Results - Mar 2025)
- Market-cap: USD 727.10 Million (Micro Cap)

Key Metrics:
- P/E: NA (Loss Making)
- Industry P/E: NA
- Dividend Yield: 0.00%
- Debt Equity: -5.05
- Return on Equity: 131.24%
- Price to Book: -20.70

Contact Details:
- Address: 180 NORTH LASALLE STREET, SUITE 1600, CHICAGO IL: 60601
- Tel: 1 512 4982670
- Fax: 1 302 6555049
- Website: https://www.xerispharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News